Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis? - ScienceDirect
How Do We Treat Inflammatory Bowel Diseases to Aim For Endoscopic Remission? - Clinical Gastroenterology and Hepatology
PDF) ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
PDF) Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis | Usha Chauhan - Academia.edu
PDF) Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study - Clinical Nutrition ESPEN
Definition of Remission and Relapse | Download Scientific Diagram
Remission - Definition, Positives and Challenges — Nutrition & Lifestyle Medicine Clinic
Exabis Library:
European Crohn´s and Colitis Organisation - ECCO - Volume 15, Issue 2
AbbVie Symposium at ECCO 2020: The Illusion of Remission - EMG-Health
Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
ECCO-EFCCA Patient Guidelines on Crohn's Disease (CD)
PDF) ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology
IBD treatment plan 'needs to be a continuous conversation'
Exabis Library:
Definition of Remission and Relapse | Download Scientific Diagram
Duration of sustained remission after treatment by induction with exclusive enteral nutrition and azathioprine in patients with Crohn's disease | Anales de Pediatría
Exabis Library:
Prognostic value of histological remission in patients with ulcerative colitis R3 박영수 / Pf. 윤혁. - ppt download
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
PDF) N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease - The Lancet Gastroenterology & Hepatology
